Therapeutic Potential of Metabolites from Lactobacillus rhamnosus and Mare's Milk in the Treatment of Dysbiosis

Keyphrases

• Therapeutic Potential 100%
• Potential Therapeutics 100%
• Inflammatory Cytokines 100%
• Mare Milk 100%
• Positive Control 100%
• Lactobacillus Rhamnosus 100%
• Dysbiosis 100%
• 5-aminosalicylic Acid (5-ASA) 100%
• Inflammatory Bowel Disease 50%
• Colon 50%
• Microbial Composition 50%
• Biological Products 50%
• Rectum 50%
• Dextran Sulfate Sodium 50%
• Ulcerative Colitis 50%
• Colitis 50%
• Therapeutic Effect 50%
• Active Metabolite 50%
• 16S rRNA Gene 50%
• Gut Microbiota 50%
• Remission 50%
• Mucous Membrane 50%
• Intestinal Microbiota 50%
• Therapeutic Value 50%
• Intestinal Microbiome 50%
• Microbial Dysbiosis 50%

INIS

• diseases 100%
• control 100%
• cytokines 100%
• milk 100%
• metabolites 100%
• lactobacillus 100%
• comparative evaluations 50%
• levels 50%
• values 50%
• inflammation 50%
• colon 50%
• pathogenesis 50%
• rectum 50%
• dextran 50%
• mucous membranes 50%
• sodium sulfates 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Mare 100%
• Lactobacillus rhamnosus 100%
• Dysbiosis 100%
• Cytokine 66%
• Aminosalicylic Acid 66%
• Intestine Flora 66%
• Inflammatory Bowel Disease 33%
• Dextran Sulfate 33%
• Therapeutic Effect 33%
• Ulcer 33%
• Ulcerative Colitis 33%
• Colitis 33%
• Remission 33%
• Biological Product 33%
• Active Metabolite 33%
• DNA 16S 33%
• Disease 33%
• Microbiome 33%